Reports for TEVA-SUCRALFATE

Brand name
TEVA-SUCRALFATE

Company Name

TEVA CANADA LIMITED

Drug Identification Number

02045702

Ingredients & Strength

ATC Code

  • A02BX
  • A02BX

ATC Descriptor

  • DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
  • DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)

Status

MARKETED
Shortage reports
Brand name Packaging size Status Date Created Date Updated Reports
TEVA-SUCRALFATE 100 Resolved 2022-06-09 2022-09-08 162303
TEVA-SUCRALFATE 500 Resolved 2019-08-29 2020-01-30 92663
TEVA-SUCRALFATE 500 Resolved 2021-12-17 2022-01-20 151468
TEVA-SUCRALFATE 100 Resolved 2021-10-07 2021-11-05 146856
TEVA-SUCRALFATE 500 Resolved 2021-09-30 2021-11-05 146469
TEVA-SUCRALFATE 100 Resolved 2021-08-27 2021-09-30 144760
TEVA-SUCRALFATE 500 Resolved 2021-06-17 2021-07-22 141113
TEVA-SUCRALFATE 500 Resolved 2021-04-29 2021-05-13 138300
TEVA-SUCRALFATE 500 Resolved 2021-04-01 2021-04-08 136759
TEVA-SUCRALFATE 500 Resolved 2020-09-24 2020-10-15 124995

Showing 11 to 20 of 22

Discontinuation reports
Brand name Packaging size Status Date Created Date Updated Reports

Showing 1 to 0 of 0